Jamieson Wellness Inc. announced on August 6, 2026 that it entered into a definitive arrangement agreement with Kirin Holdings Company, Limited, under which Kirin Holdings will acquire all issued and outstanding common shares of Jamieson Wellness for $45.75 per share in cash. The transaction values Jamieson Wellness at approximately $2.0 billion on a fully diluted equity value basis and approximately $2.5 billion on an enterprise value basis. The consideration represents a 27 percent premium to the 20-day VWAP and a 32 percent premium to the 60-day VWAP on the TSX for the period ending June 24, 2026. The transaction was unanimously approved by the Jamieson Wellness board following the unanimous recommendation of a special committee of independent directors, and voting support agreements were entered into by the company’s directors and senior officers. Completion remains subject to shareholder approval, court approval and regulatory approvals, with closing expected in the fourth quarter of 2026. The acquisition is expected to expand Kirin Holdings’ health science business into North America and add Jamieson Wellness’ vitamins, minerals and supplements platform to Kirin Holdings’ global health science portfolio.